JGC
EW icon

J. Goldman & Co’s Edwards Lifesciences EW Stock Holding History

J. Goldman & Co’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-18,666
Closed -$1.17M – 282
2020
Q1 		$1.17M Buy
18,666
+4,326
+30% +$312K 0.14% 133
2019
Q4 		$1.11M Sell
14,340
-92,826
-87% -$7.25M 0.08% 172
2019
Q3 		$7.86M Buy
+107,166
New +$7.53M 0.59% 56
2016
Q1 		– Sell
-79,662
Closed -$2.1M – 305
2015
Q4 		$2.1M Buy
+79,662
New +$2.07M 0.22% 130

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

J. Goldman & Co's EW Position: Q2 2020 in Review

J. Goldman & Co sold out of Edwards Lifesciences (EW) in Q2 2020, closing a stake of 18,666 shares — an estimated $1.17M sold.

J. Goldman & Co first reported a position in EW in Q4 2015 and held it in 4 quarters. The position peaked at $7.86M in Q3 2019. 1,048 funds tracked by Wall St. Rank hold EW as of Q2 2020.

  • J. Goldman & Co reported no remaining Edwards Lifesciences position as of Q2 2020 after selling out during the quarter.
  • J. Goldman & Co sold 18,666 Edwards Lifesciences shares in Q2 2020, an estimated $1.17M.
  • J. Goldman & Co first reported a position in Edwards Lifesciences in Q4 2015 and held it in 4 quarters.
  • J. Goldman & Co's Edwards Lifesciences position peaked at $7.86M in Q3 2019.
  • 1,048 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2020.

Based on J. Goldman & Co's 13F filing for Q2 2020, filed 14 Aug 2020.